Indocyanine Green-Loaded Ferritin Nanoparticles for Intraoperative Detection of Cancer Tissue

M. Sevieri, S. Mazzucchelli, Arianna Chesi, C. Sottani, F. Corsi
{"title":"Indocyanine Green-Loaded Ferritin Nanoparticles for Intraoperative Detection of Cancer Tissue","authors":"M. Sevieri, S. Mazzucchelli, Arianna Chesi, C. Sottani, F. Corsi","doi":"10.11159/nddte22.142","DOIUrl":null,"url":null,"abstract":"Extended Abstract Background: Nanotechnology represents one of the most promising field of study in this century, considering that its application to medicine is becoming fundamental in the diagnosis and treatment of several diseases such as cancer. Since chemotherapy often suffers from limited effectiveness and specificity against cancer cells, causing important side effects and toxicity in healthy tissues, the main clinical option is still usually represented by surgery. In this context, the development of nano-tracers with tumor specificity to achieve an accurate and timely diagnosis could be of crucial importance. In recent years, several studies have been carried out using nanoparticles of ferritin (HFn), that offer new therapeutic options, potentially allowing the specific drug delivery to cancer cells, as well as the possibility of exploiting them as nano-tracers for tumor detection and fluorescence-guided surgery (FGS) applications. Indeed, one of the most important features of HFn is its natural homing towards cancer cells thanks to the specific recognition of the transferrin-1 receptor (TfR1), which is abundantly expressed in most tumor subtypes [1-4]. Objectives: To support surgeons during intraoperative tumor and metastasis localization, we proposed the use of ferritin nanoparticles","PeriodicalId":276715,"journal":{"name":"Proceedings of the 7th World Congress on Recent Advances in Nanotechnology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 7th World Congress on Recent Advances in Nanotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11159/nddte22.142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Extended Abstract Background: Nanotechnology represents one of the most promising field of study in this century, considering that its application to medicine is becoming fundamental in the diagnosis and treatment of several diseases such as cancer. Since chemotherapy often suffers from limited effectiveness and specificity against cancer cells, causing important side effects and toxicity in healthy tissues, the main clinical option is still usually represented by surgery. In this context, the development of nano-tracers with tumor specificity to achieve an accurate and timely diagnosis could be of crucial importance. In recent years, several studies have been carried out using nanoparticles of ferritin (HFn), that offer new therapeutic options, potentially allowing the specific drug delivery to cancer cells, as well as the possibility of exploiting them as nano-tracers for tumor detection and fluorescence-guided surgery (FGS) applications. Indeed, one of the most important features of HFn is its natural homing towards cancer cells thanks to the specific recognition of the transferrin-1 receptor (TfR1), which is abundantly expressed in most tumor subtypes [1-4]. Objectives: To support surgeons during intraoperative tumor and metastasis localization, we proposed the use of ferritin nanoparticles
吲哚菁绿色负载铁蛋白纳米颗粒在术中检测肿瘤组织中的应用
背景:纳米技术是本世纪最有前途的研究领域之一,因为它在医学上的应用正在成为癌症等几种疾病的诊断和治疗的基础。由于化疗对癌细胞的有效性和特异性有限,在健康组织中会产生重要的副作用和毒性,因此临床的主要选择仍然是手术。在这种情况下,开发具有肿瘤特异性的纳米示踪剂以实现准确和及时的诊断可能至关重要。近年来,使用铁蛋白纳米颗粒(HFn)进行了几项研究,提供了新的治疗选择,可能允许将特定药物递送到癌细胞,以及利用它们作为肿瘤检测和荧光引导手术(FGS)应用的纳米示踪剂的可能性。事实上,HFn最重要的特征之一是其天然归巢于癌细胞,这要归功于对转铁蛋白-1受体(TfR1)的特异性识别,该受体在大多数肿瘤亚型中大量表达[1-4]。目的:为了支持外科医生在术中肿瘤和转移定位,我们提出使用铁蛋白纳米颗粒
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信